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Objective: We previously reported that a gelatin sheet incorporating basic fibroblast
growth factor accelerated sternal healing after bilateral internal thoracic artery
removal in normal and diabetic rats. The aim of this study was to evaluate the effects
of this therapeutic modality on sternal healing in a large-animal model before
performing a clinical trial.
Methods: After median sternotomy and bilateral internal thoracic artery removal in
a pedicled fashion, 14 beagle dogs received either a gelatin sheet incorporating basic
fibroblast growth factor (100 g per sheet) on the posterior table of the sternum
(FGF group, n 7) or did not receive a gelatin sheet (control, n 7). We compared
sternal healing 4 weeks after surgical intervention between the groups.
Results: Scintigraphic images obtained by using technetium 99 methylene diphos-
phonate bone scanning were assessed visually, and the impulse rate was quantified
30 and 60 minutes after injection of technetium 99 methylene diphosphonate to
evaluate the sternal perfusion. Sternal uptake was significantly increased in the FGF
group (30 minutes: 221%  30% vs 180%  36%; 60 minutes: 267%  26% vs
197%  42%; P  .01). Apparent sternal dehiscence, as assessed radiographically,
was observed only in the control animals. Histologically, complete healing of the
sternum with marked angiogenesis was observed in the FGF group, whereas poor
healing with limited angiogenesis was seen in the control animals. Both bone
mineral content (134  49 vs 52  32 mg, P  .01) and bone mineral density (133
 53 vs 66  32 mg/mm2, P  .05) along the incision line of the sternum, as
assessed by means of dual-energy x-ray absorptometry, were higher in the FGF
group.
Conclusions: A gelatin sheet incorporating basic fibroblast growth factor enhances
sternal perfusion and accelerates sternal bone healing in large animals.
The usefulness of bilateral internal thoracic arteries (BITAs) formyocardial revascularization has been shown in several clinicalstudies.1-4 The use of BITAs improves long-term survival as a resultof an attempt to avoid late saphenous vein occlusion and postoper-ative return of angina. However, BITA grafting has not been acommon procedure at most cardiovascular institutions in spite of
these apparent benefits. One of several reasons is that harvesting BITAs raises the
potential for an increase in sternal wound complications after median sternotomy
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because BITAs are widely recognized as providing the
major blood supply to the sternum. Although the incidence
of deep sternal wound infection is low, the potential for
increased mortality and morbidity is well documented.
Basic fibroblast growth factor (bFGF) has been well
known as one of the potent mitogens, regulating proteins
that induce the proliferation of a variety of cells, including
epithelial and mesenchymal cells, and promoting the growth
and regeneration of organs and tissues in vivo.5 Because
bFGF in its free form had biologic activities insufficient to
induce the expected results, tissue regeneration was not
successful, except in some cases.6,7 Recently, we have de-
veloped a biodegradable hydrogel composed of acidic gel-
atin to enable bFGF to be released at the site of action for a
sufficient time period by changing the water content of
hydrogels.8 We previously reported that the topical use of a
bFGF gelatin sheet applied to the sternum after the removal
of BITAs accelerates sternal healing in normal and diabetic
rats.9,10 The objective of the present study was to elucidate
the effectiveness of this therapeutic modality for sternal
healing in a large-animal model before performing a clinical
trial.
Materials and Methods
Preparation of bFGF-incorporated Gelatin Hydrogel
Sheets
Gelatin with an isoelectric point value of 4.9 was isolated from
bovine bone collagen by means of an alkaline process using
Ca(OH)2 (Nitta Gelatin Co, Osaka, Japan). Human recombinant
bFGF with an isoelectric point value of 9.6 was supplied from
Kaken Pharmaceutical Co (Tokyo, Japan). Gelatin hydrogel sheets
were made as previously described.8 Sheets were freeze-dried,
followed by impregnation with an aqueous solution containing 100
g of bFGF, to obtain gelatin hydrogels incorporating bFGF. The
prepared hydrogel sheets were rectangular (120 10 mm) and 0.7
mm thick. All experimental procedures were conducted under
sterile conditions.
Animal Experiments
Fourteen male beagle dogs weighing between 10 and 15 kg were
used in this study. Anesthesia was induced with xylazine (5 mg/
kg), ketamine hydrochloride (12.5 mg/kg), and atropine (0.01
mg/kg) administered intramuscularly. The dogs were intubated in
the supine position, and anesthesia was maintained with isoflurane
(1%-1.5%). An intravenous antibiotic was administrated before
incision (cefazolin, 500 mg per dog). After a midline skin incision
was made, the bilateral major pectoral muscles were divided from
the junction of the sternum, and the intercostal muscles on both
sides of the sternum were exposed. Median sternotomy was care-
fully performed with a rotating saw, leaving part of the sternum on
both sides. Bleeding from the bone marrow was stopped with the
use of bone wax (NESTOR, Nippon Shoji, Japan). The 14 dogs
were randomly divided into 2 groups. The FGF group (n  7) had
the BITAs removed, and a gelatin hydrogel sheet that incorporated
bFGF was placed on the posterior table of the sternum before the
sternum was closed. The control group (n  7) had the BITAs
removed, and the sternum was closed without the gelatin hydrogel
sheet. BITAs were harvested in a pedicled fashion and were then
ligated with 2-0 silk sutures near the takeoff point and at the distal
bifurcation. When the gelatin hydrogel sheets with incorporated
bFGF (100 g per sheet) were placed in the animals, the internal
thoracic artery (ITA) beds were also covered by the sheet from the
inside of the chest wall, and the implant was stabilized with 5-0
polypropylene sutures on all sides to avoid movement behind the
sternum. After positive end-expiratory pressure had been applied
to fully inflate the lungs, the sternum was parasternally closed with
6 interrupted, braided polyester sutures. The muscle layer and the
skin were carefully sutured with 2-0 nylon monofilaments. All the
animal experiments were performed according to Kyoto Univer-
sity’s institutional guidelines for animal experimentation.
Bone Scintigraphy
Bone scintigraphy was performed 4 weeks after the operation.
Radioactive marked technetium-99m methylene diphosphonate
(99mTc-MDP) was used as an indicator. 99mTc-MDP was supplied
by Nihon Medi-Physics Co (Nishinomia, Japan). The dogs were
anesthetized with xylazine (5 mg/kg) and ketamine hydrochloride
(12.5 mg/kg), and the imaging was performed 30 and 60 minutes
after injection of 291 MBq (approximately 0.79 mL) of 99mTc-
MDP through the peripheral vein. All scintigraphic images were
assessed visually by an investigator blinded to treatment assign-
ments.
Computer-assisted image analysis was performed to quantify
tracer uptake in the sternal wound. The sternum, as the region of
interest (ROI), was divided into 3 parts (manubrium, corpus, and
distal sternum). The posterior mediastinal cavity was the reference
ROI because this region was not involved in the operation, and the
count rate of this reference ROI was defined as 100%. The mean
number of counts per pixel was calculated for each ROI and
compared statistically.
Assessment of Bone Formation
All dogs were killed by means of intravenous administration of a
lethal dose of sodium pentobarbital 4 weeks after the operation.
The sternum was excised and fixed in 10-wt% formaldehyde
solution in primary buffer solution for 4 days for assessment of the
extent of bone regeneration. Bone regeneration of the sternum was
assessed radiographically and by means of histologic examination.
Soft-tissue (high-contrast) radiographs of the sternum were taken
at 38 kV and 2 mA for 45 seconds by using an x-ray apparatus
(type CMB; Koizumi X-Senkosha, Tokyo, Japan). Photographs of
formalin-fixed bone specimens from different experimental groups
were taken with the same type of x-ray film.
Bone regeneration of the sternum was also assessed by means
of quantification of the bone mineral content (BMC) and bone
mineral density (BMD) and by means of histologic examination.
The BMD and BMC of each sternum were analyzed on the whole
sternum and also on the 60 1 mm2 ROI along the sternal incision
line by dual-energy x-ray absorptometry with a bone mineral
analyzer (Dichroma Scan 600; Aloka Co, Tokyo, Japan). The
instrument was calibrated with a phantom of known mineral con-
tent. Each scan was performed at a speed of 20 mm/s, and the
scanning length was 2 mm.
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Histologic Examinations for Angiogenesis and Sternal
Regeneration
After assessment for bone formation, bone specimens were demin-
eralized in 10-wt% ethyelendiamine tetraacetic acid solution at
4°C for 3 days, embedded in paraffin, and sectioned at a thickness
of 10 m. Sections were obtained at the third, fourth, and fifth
intercostal spaces of the sternum and stained with hematoxylin and
eosin and azan.
The assessment of vascular density, including both arterioles
(25 and100 m in external diameter) and capillaries (25 m
in external diameter), in preparations stained with hematoxylin and
eosin was carried out in a 200 field (0.442 mm2 per unit area).
Five fields were chosen randomly from the connective tissue
around the sternum. Two pathologists blinded to treatment counted
the number of vessels per unit area, as described previously.10
Statistical Analysis
Experimental results are expressed as the mean  SD. Statistical
analysis comparing 2 groups was performed with the Wilcoxon
rank sum test for means or the Fisher exact probability test for
categoric variables.
Results
Radionuclide Imaging
Scintigraphic images were evaluated visually and quantita-
tively. Blinded comparison between the 2 groups revealed
higher homogenous tracer uptake in the sternum in the FGF
group (Figure 1, A) compared with that in the control group
(Figure 1, B). The quantitative analysis of tracer uptake is
summarized in Figure 2. Sternal uptake in the FGF group
was significantly greater than that in the control animals at
both 30 and 60 minutes after 99mTc-MDP injection (30
minutes: 221%  30% for the FGF group vs 180%  36%
for the control group; 60 minutes: 267% 26% for the FGF
group vs 197%  42% for the control group; P  .01).
Histologic analysis suggested an increase of sternal per-
fusion in the FGF group. Both capillaries and arterioles in
the connective tissue around the regenerated sternum were
more evident in the FGF group than in the control group
(Figure 3). Figure 4 shows the number of arterioles and
capillaries per unit area around the sternum 4 weeks after
surgical intervention in both groups. The number of vessels
per unit area around the sternum increased to a greater
extent in the FGF group than in the control group (40.0 
3.5 vessels per unit area for the FGF group vs 18.1  5.6
vessels per unit area for the control group; P  .01).
Assessment of Bone Formation
High-contrast radiographic images of the sternum 4 weeks
after surgical treatment are shown in Figure 5. Dehiscence
of the separated original sternum was observed in 2 dogs in
the control group. In contrast, all dogs in the FGF group had
sternal union and almost complete bone regeneration (rate
Figure 1. Sternal scintiscans with 99mTc-MDP 4 weeks after surgical intervention showing increased uptake in the
FGF group (A) and reduced uptake in the control group (B).
Figure 2. Quantitative analysis of sternal uptake 30 and 60 min-
utes after the injection of 99mTc-MDP 4 weeks after surgical
treatment of the FGF and control groups.
Iwakura et al Cardiopulmonary Support and Physiology
The Journal of Thoracic and Cardiovascular Surgery ● Volume 126, Number 4 1115
CS
P
of sternal dehiscence  0.0% vs 71.3%; P  .02). In all
dogs with sternal dehiscence in the control group, none had
evidence of macroscopic abscess in the anterior mediasti-
num. There were no macroscopic findings indicating that
the implanted gelatin sheets remained 4 weeks after surgical
intervention.
Figure 6, A and B, shows histologic sections of the
sternum 4 weeks after surgical intervention. Histologic ex-
amination revealed evidence of a little endochondrial ossi-
fication around the original sternum in both groups. How-
ever, complete bone regeneration along the incision of the
sternum was observed only in the FGF group (Figure 6, C).
In contrast, histologic analysis of the control group revealed
invasion of fibrous tissue and inflammatory cells into the
separated sternal space rather than sternal regeneration (Fig-
ure 6, D).
The BMC (1082  413 vs 749  216 mg) and BMD
(107  22 vs 84  15 mg/mm2) of the whole sternum, as
assessed by means of dual-energy x-ray absorptometry, did
not indicate a significant difference between the FGF and
control groups, as shown in Figure 7. However, the BMC
along the incision line of the sternum in the FGF group was
significantly higher than that in the control group (134 49
vs 52  32 mg, P  .01). Also, the BMD in the FGF group
showed a significant increase compared with that in the
control group (133  53 vs 66  32 mg/mm2, P  .05)
because the BMD was calculated at the same 60  1 mm2
ROI in all samples.
Discussion
Bone scintigraphy with 99mTc-MDP is commonly used in
the diagnosis of bone disease. 99mTc-MDP is a radionuclide
with excellent imaging characteristics, including pure
gamma emission with a single low-energy gamma peak, a
short half-life (6 hours), and a reasonable cost per dose.11
Although many characteristics of the mechanism of accu-
mulation to bone have not been clarified, it is generally
assumed that 99mTc-MDP accumulates at the sites of active
bone metabolism. Several authors have already evaluated
the sternal perfusion after harvesting bilateral or unilateral
ITAs using scintigraphic techniques.12,13 Using bone scans,
Cohen and colleagues14 have shown that a pedicled left ITA
graft to the left anterior descending artery reduces blood
flow to the left side of the sternum during the acute post-
operative period. In this study our results reveal higher
uptake in the FGF group compared with that in the control
group both at 30 and 60 minutes after the injection of
99mTc-MDP. Moreover, histologic sections in the FGF
group disclose marked angiogenesis around the regenerated
sternum and active bone metabolism along the incision line
of the sternum. Also, there is little possibility that the
increased uptake in the FGF group was due to increased
inflammation caused by the delivery system of bFGF. We
Figure 3. Micrographs stained with hematoxylin and eosin showing new blood vessel formation in connective
tissue around the sternum 4 weeks after surgical treatment of the FGF (A) and control (B) groups. Increased
numbers of capillaries and arterioles are indicated (arrowheads). NB, New bone.
Figure 4. Quantitative analysis of the number of vessels in con-
nective tissue around the sternum 4 week after surgical treatment
of the FGF and control groups.
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could not find the unabsorbable gelatin sheet 4 weeks after
the operation in the FGF group, and the histologic assess-
ment in the FGF group did not detect more inflammatory
cells around the regenerated sternum compared with those
seen in the control group. These findings suggest that the
delivery system has a minimum inflammatory effect at the
scintigraphic assessment. We believe that the higher uptake
of 99mTc-MDP demonstrates active sternal bone metabolism
as a result of an increase of sternal perfusion because the
quantitative analysis of the vascular density around the
sternum also supported this speculation.
Recently, modifications in the technique of ITA harvest-
ing, such as skeletonization of the ITA, have been suggested
as a means of preserving the collateral blood supply to the
sternum after ITA mobilization.15,16 This concept has also
been supported in some anatomic studies on sternal blood
supply.17-19 Pietrasik and colleagues20 have reported that
most ITA branches can originate as a common trunk, and
potential anastomoses can occur across these joint branches
after ITA mobilization. The blood flow to the sternum might
be preserved by division of the ITA branches close to the
ITA itself after careful harvesting of the common trunk.
However, angiographic study in human subjects21 has re-
vealed numerous variations in ITA branching patterns. As a
result, even careful skeletonization can destroy collaterals
from the lateral chest wall to the sternum (eg, solitary
branches). Thus, skeletonization might be useful for some
patients but not for all patients who need or would poten-
tially benefit from BITA grafts for coronary revasculariza-
tion. On the contrary, this trial with the gelatin hydrogel
sheet incorporating bFGF is a novel regenerative approach
to the devascularized sternum after BITA harvesting. Our
data in this study reveal that a gelatin hydrogel sheet incor-
porating bFGF improves sternal healing after harvesting
BITAs, even in a pedicled fashion that might cause severe
sternal ischemia. Moreover, although diabetic patients are
considered at increased risk for sternal wound complica-
tions and thus have been largely excluded from receiving
BITA grafting,22,23 this method improved sternal healing
after BITA removal, even in diabetic animals.10 It is very
likely that this method can potentially extend the use of
BITAs in coronary bypass surgery.
Because bFGF functions as a potent mitogen for mesen-
chymal cells, it has the potential to be a key factor for tissue
engineering of the sternum, inducing not only neovascular-
ization but also osteogenesis. This osteogenic effect of
bFGF consists of acceleration of callus remodeling both by
means of osteoblastic callus formation and osteoclastic cal-
lus resorption.24 In this study we did not evaluate the group
that had the gelatin sheets without incorporating bFGF
because the empty gelatin had no effect in enhancing bone
formation in our previous investigation using skull-defect
models in rabbits.8 Our histologic results also confirm that
the gelatin hydrogels incorporating bFGF accelerate sternal
regeneration after median sternotomy, even in a large ani-
mal. We have previously measured the BMD and BMC in
a small-animal model as an indicator of qualitative and
quantitative analysis, respectively. Both the BMD and BMC
measurements in the whole sternum showed no significant
differences between the 2 groups in this study, despite those
in the FGF group along the incision line of the sternum
being significantly increased compared with those in the
Figure 5. Radiograph showing sternal bone regeneration 4 weeks after surgical treatment in dogs. A, Almost
complete sternal regeneration was seen in the FGF group. B, Obvious sternal dehiscence was observed in the
control group (arrowheads).
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control group. This might be caused by the much smaller
area of regenerated sternum compared with the nonregen-
erated sternum in a large animal. Also, the FGF group was
associated with a significant trend toward decreased sternal
dehiscence in spite of no mechanical care of the sternum
postoperatively. These findings suggest that the regenerated
sternum induced by a gelatin sheet incorporating bFGF
might be strong and stable enough to be helpful clinically.
There are several limitations in the present study. First,
the sternal feature, even in a large animal, is not the same as
that in a human subject. It is undeniable that structural
differences might influence sternal healing induced by the
bFGF sheet. However, a pilot study with cynomolgus mon-
keys showed that the use of bFGF sheets accelerated sternal
regeneration after BITA mobilization, although there was
some (although fewer) structural differences from a human
subject. Therefore we believe that our method can enhance
sternal healing, even in human subjects. Second, hematox-
ylin-and-eosin staining might not be optimal for the assess-
ment of vascular density. However, it is meaningful to
evaluate the vascular density by using hematoxylin-and-
eosin staining as a blood supply to the sternum because the
results would reflect the number of large vessels rather
than capillaries around the regenerated sternum. The final
potential limitation concerns the systemic effects of
bFGF. Specifically, the angiogenic potential of bFGF
might cause a clinical worsening of symptoms in patients
with diabetic retinopathy and neoplasm. However, bFGF in
its free form (ie, a higher serum level of bFGF) has been
commercially available as a treatment for skin ulcers in
Japan, with no reported problems. In addition, clinical trials
of bFGF for the treatment of myocardial ischemia have
revealed no complications of exogenously administrated
protein.25
Figure 6. Histologic cross-sections of azan-stained sternum were obtained 4 weeks after surgical treatment.
Whole sternal feature in the FGF (A) or control (B) groups was shown at a low magnification (2). Regenerated
sternal bone was observed along the incision line of the sternum only in the FGF group (C). Fibrous tissue instead
of regenerated bone invaded the space between the separated original sternum (D). OS, Original sternum; NB, new
bone.
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In conclusion, the gelatin sheet incorporating bFGF en-
hances sternal perfusion and accelerates sternal bone heal-
ing, despite pedicled BITA removal after median sternot-
omy, even in large animals, especially by inducing
neovascularization and osteogenesis. These results warrant
further investigation in a clinical trial. We are in the process
of making an application for this clinical trial, which has
been submitted to the ethical committee at Kyoto Univer-
sity, Japan.
We acknowledge Satoshi Teramukai (Department of Clinical
Trial Treatment Translational Research Center, Kyoto University)
for statistical collaboration in this article.
References
1. Buxton B, Komeda M, Fuller JA, Gordon I. Bilateral internal thoracic
artery grafting may improve outcome of coronary artery surgery.
Circulation. 1998;98(Suppl):II1-6.
2. Endo M, Nishida H, Tomizawa Y, Kasanuki H. Benefit of bilateral
internal mammary artery grafts over single IMA graft for multiple
coronary artery bypass grafting. Circulation. 2001;104:2164-70.
3. Lytle BW, Blackstone EH, Loop FD, Houghtaling PL, Arnold JH,
Akhrass R, et al. Two internal thoracic artery grafts are better than one.
J Thorac Cardiovasc Surg. 1999;117:855-72.
4. Pick AW, Orszulak TA, Anderson BJ, Schaff HV. Single versus
bilateral internal mammary artery grafts: 10-year outcome analysis.
Ann Thorac Surg. 1997;64:599-605.
5. Rifkin DB, Moscatelli D. Recent developments in the cell biology of
basic fibroblast growth factor. J Cell Biol. 1989;109:1-6.
6. Schliephake H, Newkam FW, Lohr A, Hutmacher D. The use of basic
fibroblast growth factor (bFGF) for enhancement of bone ingrowth
into pyrolized bovine bone. Int J Oral Maxillofac Surg. 1995;24:
181-6.
7. Aebischer P, Salessiotis AN, Winn SR. Basic fibroblast growth
factor released from synthetic guidance channels facilitates periph-
eral nerve regeneration across lone nerve gaps. J Neurosci Res.
1989;23:282-9.
8. Tabata Y, Yamada K, Miyamoto S, Nagata I, Kikuchi H, Aoyama I, et
al. Bone regeneration by basic fibroblast growth factor complexed with
biodegradable hydrogels. Biomaterials. 1998;19:807-15.
9. Iwakura A, Tabata Y, Miyao M, Ozeki M, Tamura N, Ikai A, et al.
Novel method to enhance sternal healing after harvesting bilateral
internal thoracic arteries with use of basic fibroblast growth factor.
Circulation. 2000;102(Suppl):III307-11.
10. Iwakura A, Tabata Y, Tamura N, Doi K, Nishimura K, Nakamura T,
et al. Gelatin sheet incorporating basic fibroblast growth factor en-
hances healing of devascularized sternum in diabetic rats. Circulation.
2001;104(Suppl):I325-9.
11. Okamoto YM. Mechanism of accumulation of 99mTc-MDP to bone:
correlation of in vivo data with in vitro data. Radiat Med. 1997;15:
209-15.
12. Korbmacher B, Schumitt HH, Bauer G, Hoffmann M, Vosberg H,
Simic O, et al. Change of sternal perfusion following preparation of the
internal thoracic artery—a scintigraphical study. Eur J Cardiothorac
Surg. 2000;17:58-62.
13. Carrier M, Gregoire J, Tronc F, Cartier R, Leclerc Y, Pelletier LC.
Effect of internal mammary artery dissection on sternal vasculariza-
tion. Ann Thorac Surg. 1992;53:115-9.
14. Cohen AJ, Lookman J, Lorberboym M, Bder O, Cohen N, Medalion B,
et al. Assessment of sternal vascularity with single photon emission
computed tomography after harvesting of the internal thoracic artery.
J Thorac Cardiovasc Surg. 1999;118:496-502.
15. Bical O, Braunberger E, Fischer M, Robinnault J, Foiret JC, Fromes
Y, et al. Bilateral skeletonized mammary artery grafting: experience
with 560 consecutive patients. Eur J Cardiothorac Surg. 1996;10:
971-6.
16. Calafiore AM, Vitolla G, Iaco AL, Fino C, Giammarco GD,
Marchesani F, et al. Bilateral internal mammary artery grafting: mid-
term results of pedicled versus skeletonized conduits. Ann Thorac
Surg. 1999;67:1637-42.
17. Jesus RA, Acland RD. Anatomic study of the collateral blood supply
of the sternum. Ann Thorac Surg. 1995;59:163-8.
18. Henriquez-Pino JA, Gomes WJ, Prates JC, Buffolo E. Surgical anat-
omy of the internal thoracic artery. Ann Thorac Surg. 1997;64:1041-5.
19. Arnold M. The surgical anatomy of sternal blood supply. J Thorac
Cardiovasc Surg. 1972;64:596-610.
20. Pietrasik K, Bakon L, Zdunek P, Wojda-Gradowska U, Dobosz P,
Figure 7. BMC (left) and BMD (right) were analyzed on the whole sternum and along the sternal median incision
line (60  1 mm2 ROI) by means of dual-energy x-ray absorptometry after surgical treatment of the FGF and control
groups.
Iwakura et al Cardiopulmonary Support and Physiology
The Journal of Thoracic and Cardiovascular Surgery ● Volume 126, Number 4 1119
CS
P
Kolesnik A. Clinical anatomy of internal thoracic artery branches. Clin
Anat. 1999;12:307-14.
21. Peric M, Sagic D, Miric M, Bojic M. Angiographic characteristics of
the internal thoracic artery—anatomic variations and their surgical
importance. Med Pregl. 2000;53:245-9.
22. Matsa M, Paz Y, Gurevitch J, Shapira I, Kramer A, Pevny D, et al.
Bilateral skeletonized internal thoracic artery grafts in patients with
diabetes. J Thorac Cardiovasc Surg. 2001;121:668-74.
23. Trick WE, Scheckler WE, Tokars JI, Jones KC, Reppen ML, Smith
EM, et al. Modifiable risk factors associated with deep sternal site
infection after coronary artery grafting. J Thorac Cardiovasc Surg.
2000;199:108-14.
24. Iwakura A, Tabata Y, Nishimura K, Shimizu Y, Fujita M, Komeda M.
Basic fibroblast growth factor may improve devascularized sternal
healing. Ann Thorac Surg. 2000;70:824-8.
25. Laham R, Sellke F, Edelman E, Pearlman JD, Ware A, Brown DL, et
al. Local perivascular delivery of basic fibroblast growth factor in
patients undergoing coronary bypass surgery: results of a phase I
randomized, double-blind, placebo-controlled trial. Circulation. 1999;
100:1865-71.
Cardiopulmonary Support and Physiology Iwakura et al
1120 The Journal of Thoracic and Cardiovascular Surgery ● October 2003
CSP
